Lexicon Pharmaceuticals, Inc. (LXRX)
Total Valuation
LXRX has a market cap or net worth of $539.26 million. The enterprise value is $474.01 million.
Market Cap | 539.26M |
Enterprise Value | 474.01M |
Important Dates
The last earnings date was Monday, March 11, 2024, before market open.
Earnings Date | Mar 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LXRX has 246.24 million shares outstanding. The number of shares has increased by 33.43% in one year.
Shares Outstanding | 246.24M |
Shares Change (YoY) | +33.43% |
Shares Change (QoQ) | +0.11% |
Owned by Insiders (%) | 1.67% |
Owned by Institutions (%) | 82.30% |
Float | 100.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 447.89 |
Forward PS | 30.33 |
PB Ratio | 5.79 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 393.69 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 1.13.
Current Ratio | 5.60 |
Quick Ratio | 5.42 |
Debt / Equity | 1.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.52 |
Financial Efficiency
Return on equity (ROE) is -139.70% and return on invested capital (ROIC) is -86.79%.
Return on Equity (ROE) | -139.70% |
Return on Assets (ROA) | -71.90% |
Return on Capital (ROIC) | -86.79% |
Revenue Per Employee | $4,225 |
Profits Per Employee | -$621,470 |
Employee Count | 285 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.45% in the last 52 weeks. The beta is 1.28, so LXRX's price volatility has been higher than the market average.
Beta (1Y) | 1.28 |
52-Week Price Change | +3.45% |
50-Day Moving Average | 2.30 |
200-Day Moving Average | 1.74 |
Relative Strength Index (RSI) | 51.46 |
Average Volume (30 Days) | 4,806,726 |
Short Selling Information
The latest short interest is 21.35 million, so 8.67% of the outstanding shares have been sold short.
Short Interest | 21.35M |
Short Previous Month | 21.07M |
Short % of Shares Out | 8.67% |
Short % of Float | 21.34% |
Short Ratio (days to cover) | 3.31 |
Income Statement
In the last 12 months, LXRX had revenue of $1.20 million and -$177.12 million in losses. Loss per share was -$0.80.
Revenue | 1.20M |
Gross Profit | 1.12M |
Operating Income | -171.75M |
Pretax Income | -177.12M |
Net Income | -177.12M |
EBITDA | -163.46M |
EBIT | -164.02M |
Loss Per Share | -$0.80 |
Balance Sheet
The company has $170.03 million in cash and $104.77 million in debt, giving a net cash position of $65.25 million or $0.27 per share.
Cash & Cash Equivalents | 170.03M |
Total Debt | 104.77M |
Net Cash | 65.25M |
Net Cash Per Share | $0.27 |
Equity / Book Value | 93.11M |
Book Value Per Share | 0.38 |
Working Capital | 145.00M |
Cash Flow
In the last 12 months, operating cash flow was -$161.90 million and capital expenditures -$470,000, giving a free cash flow of -$162.37 million.
Operating Cash Flow | -161.90M |
Capital Expenditures | -470,000 |
Free Cash Flow | -162.37M |
FCF Per Share | -$0.73 |
Margins
Gross margin is 92.94%, with operating and profit margins of -14,264.95% and -14,710.88%.
Gross Margin | 92.94% |
Operating Margin | -14,264.95% |
Pretax Margin | -14,710.88% |
Profit Margin | -14,710.88% |
EBITDA Margin | -13,576.74% |
EBIT Margin | -13,622.76% |
FCF Margin | -13,485.63% |
Dividends & Yields
LXRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.43% |
Shareholder Yield | -33.43% |
Earnings Yield | -32.84% |
FCF Yield | -30.11% |
Analyst Forecast
The average price target for LXRX is $8.00, which is 233.33% higher than the current price. The consensus rating is "Buy".
Price Target | $8.00 |
Price Target Difference | 233.33% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 315.11% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 21, 2015. It was a reverse split with a ratio of 1:7.
Last Split Date | May 21, 2015 |
Split Type | Reverse |
Split Ratio | 1:7 |
Scores
LXRX has an Altman Z-Score of -10 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -10 |
Piotroski F-Score | 2 |